参考图片
Expression of IP-10 by stimulated human monocytes. Human PBMC were stimulated for 24 hours with Human Interferon-γ (1500 U/ml final concentration; Cat. No. 554617) in the presence of GolgiStop™ (2 µM final concentration; Cat. No. 554724). The PBMC were harvested, fixed, permeabilized, and stained with 0.05 µg of PE-mouse anti-human IP-10 antibody (PE-6D4/D6/G2, Cat. No. 555049) following BD Pharmingen staining protocol (see Figure, left panel). The data reflect gating on monocytes, based on forward and side scattered light signals. To demonstrate specificity of staining, binding by the PE-6D4/D6/G2 antibody was blocked by preincubation of the fixed/permeabilized cells with excess unlabeled 6D4/D6/G2 antibody (5 µg; middle panel) prior to staining with the PE-6D4/D6/G2 antibody. The level of nonspecific staining was assessed using the PE-mouse IgG2a isotype control (0.05 µg; PE-G155-178; Cat. No. 554648; right panel). The quadrant markers for the bivariate dot plots were set based on the autofluorescence control and verified using the unlabeled antibody blocking control.
本文来自投稿,不代表本人立场,如若转载,请注明出处:http://www.iamyjet.com/kangti/9788.html